Home / World Marketplace / Archive by category Global Health & Biotech (Page 58)

Archive by category Global Health & Biotech

Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation

Duke-NUS Medical School’s Dr. Linfa Wang Awarded GVN’s 2024 Robert C. Gallo Award for Scientific Excellence and Leadership DURBAN, South Africa, Sept. 18, 2024 (Korea Bizwire) – The Global Virus Network concluded its annual meeting of closed scientific sessions held 16-18 September 2024 with a press conference. Co-hosted by the Centre for the AIDS Programme of Research in South Africa [...]

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the evolving demands of primary hip surgery – including the increased adoption of anterior approach procedures – the CATALYSTEM Primary Hip System features a triple-taper stem design [...]

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks’ proprietary antibody-drug conjugate development platforms VANCOUVER, British Columbia, Sept. 18, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat cancers and [...]

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Topline data from FIBRONEER™-IPF show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] at week 52 versus placebo. The FIBRONEER™-IPF trial is the largest trial in idiopathic pulmonary fibrosis (IPF) conducted to date. Patients were recruited in over 330 sites and in [...]

Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs

WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (Korea Bizwire) – Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadshow (September 17-20) to share the unparalleled time, cost and quality opportunities for early phase US biotechs. Register Here Key Avance Clinical Australia [...]

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12 (Korea Bizwire) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price [...]

World Stroke Organization and Philips call for action to expand access to life-saving stroke care

September 10, 2024 Joint policy paper provides recommendations for effective policymaking and investments in stroke centers with specialized treatments to improve health outcomes and reduce costs Timely access to mechanical thrombectomy – a proven minimally invasive therapy to remove the blood clot that caused the stroke – has the potential to revolutionize treatment for major ischemic [...]

Vaping Expected to Increase COPD Health and Economic Burden by 2050

New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates. 88.7 million new COPD hospitalizations projected across Western Europe between 2019 – 2050 Vaping projected to incur almost €30 billion additional [...]

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

AMSTERDAM, Sept. 10, 2024 (Korea Bizwire) – The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine Index, the Foundation examined the [...]